ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Faculty Opinions recommendation of Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.734506216.793579336
◽
2020
◽
Author(s):
Nathalie Gaspar
Keyword(s):
Adult Patients
◽
Phase 2
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Metastatic Osteosarcoma
◽
Phase 2 Study
Download Full-text
Related Documents
Cited By
References
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
The Lancet Oncology
◽
10.1016/s1470-2045(18)30742-3
◽
2019
◽
Vol 20
(1)
◽
pp. 120-133
◽
Cited By ~ 68
Author(s):
Florence Duffaud
◽
Olivier Mir
◽
Pascaline Boudou-Rouquette
◽
Sophie Piperno-Neumann
◽
Nicolas Penel
◽
...
Keyword(s):
Adult Patients
◽
Phase 2
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Metastatic Osteosarcoma
◽
Phase 2 Study
Download Full-text
SAT0110 Efficacy and Safety of Pateclizumab (Anti-Lymphotoxin-Alpha) in Dmard-Ir Patients: Results of a Randomized, Double-Blind, Placebo-Controlled Head-To-Head Phase 2 Study with Adalimumab
Annals of the Rheumatic Diseases
◽
10.1136/annrheumdis-2013-eular.1836
◽
2013
◽
Vol 72
(Suppl 3)
◽
pp. A617.2-A618
Author(s):
W. Kennedy
◽
P. Horn
◽
Z. Su
◽
K. Basu
◽
A. Herman
◽
...
Keyword(s):
Phase 2
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 2 Study
◽
Lymphotoxin Alpha
Download Full-text
Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Active Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
SSRN Electronic Journal
◽
10.2139/ssrn.3523879
◽
2020
◽
Author(s):
Yoshiya Tanaka
◽
Tsutomu Takeuchi
◽
Hisashi Yamanaka
◽
Toshihiro Nanki
◽
Hisanori Umehara
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Monoclonal Antibody
◽
Active Rheumatoid Arthritis
◽
Inadequate Response
◽
Phase 2
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 2 Study
Download Full-text
Double-blind, placebo-controlled, randomized, phase 2 study to evaluate the efficacy and safety of maintenance therapy with anti-TA-MUC1 monoclonal antibody PankoMab after chemotherapy in patients with recurrent epithelial ovarian carcinoma.
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.tps5622
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. TPS5622-TPS5622
Author(s):
Jonathan A. Ledermann
◽
Ingo von Broen
◽
Frank Zimmermann
◽
Johannes Nippgen
◽
Steffen Goletz
Keyword(s):
Monoclonal Antibody
◽
Maintenance Therapy
◽
Ovarian Carcinoma
◽
Epithelial Ovarian Carcinoma
◽
Phase 2
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 2 Study
◽
Randomized Phase 2
Download Full-text
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide
Journal of Hematology & Oncology
◽
10.1186/1756-8722-5-71
◽
2012
◽
Vol 5
(1)
◽
Cited By ~ 39
Author(s):
Eunice S Wang
◽
Roger M Lyons
◽
Richard A Larson
◽
Sunil Gandhi
◽
Delong Liu
◽
...
Keyword(s):
Myelodysplastic Syndrome
◽
Phase 2
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 2 Study
Download Full-text
Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Active Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Results of a Randomized, Double‐blind, Placebo‐controlled Phase 2 study
Arthritis & Rheumatology
◽
10.1002/art.41555
◽
2020
◽
Author(s):
Yoshiya Tanaka
◽
Tsutomu Takeuchi
◽
Hisashi Yamanaka
◽
Toshihiro Nanki
◽
Hisanori Umehara
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Monoclonal Antibody
◽
Active Rheumatoid Arthritis
◽
Inadequate Response
◽
Phase 2
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 2 Study
Download Full-text
1023-96 A randomized double-blind placebo-controlled phase 2 study on the efficacy and safety of fasudil in patients with stable angina
Journal of the American College of Cardiology
◽
10.1016/s0735-1097(04)91080-7
◽
2004
◽
Vol 43
(5)
◽
pp. A254
Author(s):
Ralph M Vicari
◽
Bernard Chaitman
◽
Deborah Keefe
◽
William B Smith
◽
Steven G Chrysant
◽
...
Keyword(s):
Stable Angina
◽
Phase 2
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 2 Study
Download Full-text
Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study
Diabetes Care
◽
10.2337/dc14-1044
◽
2014
◽
Vol 37
(12)
◽
pp. 3253-3261
◽
Cited By ~ 43
Author(s):
Aaron Vinik
◽
Julio Rosenstock
◽
Uma Sharma
◽
Karen Feins
◽
Ching Hsu
◽
...
Keyword(s):
Neuropathic Pain
◽
Phase 2
◽
Proof Of Concept
◽
Efficacy And Safety
◽
Double Blind
◽
Peripheral Neuropathic Pain
◽
Double Blind Placebo
◽
Active Comparator
◽
Phase 2 Study
Download Full-text
O4-11-06: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CRENEZUMAB IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE
Alzheimer s & Dementia
◽
10.1016/j.jalz.2014.04.450
◽
2014
◽
Vol 10
◽
pp. P275-P275
◽
Cited By ~ 14
Author(s):
Jeffrey Cummings
◽
William Cho
◽
Michael Ward
◽
Michel Friesenhahn
◽
Flavia Brunstein
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Phase 2
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 2 Study
Download Full-text
A double-blind, placebo-controlled, randomized, phase 2 study to evaluate the efficacy and safety of switch maintenance therapy with the anti-TA-MUC1 antibody PankoMab-GEX after chemotherapy in patients with recurrent epithelial ovarian carcinoma
Annals of Oncology
◽
10.1093/annonc/mdx440.035
◽
2017
◽
Vol 28
◽
pp. v626
◽
Cited By ~ 6
Author(s):
J. Ledermann
◽
J. Sehouli
◽
B. Zurawski
◽
F. Raspagliesi
◽
U. De Giorgi
◽
...
Keyword(s):
Maintenance Therapy
◽
Ovarian Carcinoma
◽
Epithelial Ovarian Carcinoma
◽
Phase 2
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 2 Study
◽
Switch Maintenance Therapy
◽
Randomized Phase 2
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close